1. Xong T-Y. (2020) Coronaviruses and the cardiovascular system: acute and long-term implication. European Heart Journal, ehaa231. http// doi org/10.1093/eurheart/ehaaa231. Published: 18 March. 2. Li B. (2020) Prevalence and impact of cardiovascular metabolic Diseases on COVID-19 in China. Clin Res Cardiol., Mar 11. doi: 10.1007/s00392-020-01626-9. 3. Severin E.S. (2008) Biologicheskaya himiya. M.: OOO "Medicinskoe informacionnoe agentstvo", 364 p. (in Russian) 4. Valenza F. (2005) Lactat as a marker of energy failure in critically ill patients: hypothesis. Critical Care, vol. 5, no 6, pp. 588–593. 5. Poole R.C. (1993) Transport of lactate and other monocarboxylates across mammalian plasma membranes. American Journal of Physiology, vol. 264, pp. 761–782. 6. Hashimoto T., Brooks G.A. (2008) Mitochondrial lactate oxidation complex and an adaptive role for lactate production. Med Sci Sports Exerc., Mar., vol. 40(3), pp. 486–94. 7. (2013) Eur Heart J., vol. 34, pp. 2949–3003. doi: 10.1093 / eurheartj/eht296. 8. Mazur I.A. (2005) Tiotriazolin. Zaporozh'e, 146 p. (in Russian) 9. Netyazhenko V.Z., Mal'chevskaya T.I. (2010) Vozmozhnosti metabolicheskoj terapii v lechenii ishemicheskoj bolezni serdca: opyt dvojnogo slepogo randomizirovannogo mul'ticentrovogo issledovaniya. Listapad, no 22 (251), pp. 1–5.